FMP
Armata Pharmaceuticals, Inc.
ARMP
AMEX
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
2.51 USD
-0.155 (-6.18%)
About
ceo
Dr. Deborah L. Birx M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.armatapharma.com
exchange
AMEX
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
CIK
0000921114
ISIN
US04216R1023
CUSIP
04216R102
Address
4503 Glencoe Avenue
Phone
858 829 0829
Country
US
Employee
66
IPO Date
May 20, 1994
Summary
CIK
0000921114
Exchange
AMEX
Industry
Biotechnology
Sector
Healthcare
CUSIP
04216R102
ISIN
US04216R1023
Country
US
Price
2.51
Beta
0.7
Volume Avg.
15.91k
Market Cap
90.73M
Shares
-
52-Week
1.07-5.26
DCF
-0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.31
P/B
-
Website
https://www.armatapharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ARMP News
It looks like there's no news available.
